Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem ...
South San Francisco, CA, Nov. 14, 2024 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutes dedicated to regenerative medicine, marked a historic ...
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and ...
There is no shortage of myths and misconceptions when it comes to stem cell research and regenerative medicine. Here we address the most common concerns. If you have more questions that aren’t ...
What is the California Institute for Regenerative Medicine (CIRM)? CIRM, California’s Stem Cell Agency, was created by the voters of California in 2004 when they overwhelmingly passed Proposition 71, ...
Stem cells have the potential to treat a wide range of diseases. Here, discover why these cells are such a powerful tool for treating disease and what hurdles experts face before new therapies reach ...
Foundation – Discovery Stage Research Projects Qiong Annabel Wang Utilizing Age-Specific Adipocyte Progenitor Cells for Cell Therapy in Older Patients $1,508,997 Research Training Grant Dr. Michael E.
ReMIND-L (DISC4) applications now closed. ReMIND-X applications expected to post in Q4 2024. The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world-class ...
have the ability to divide and create an identical copy of themselves, a process called self-renewal; and can also divide to form cells that mature into cells that make up every type of tissue and ...
Six1 is a member of the six-homeodomain family of transcription factors. Six1 is expressed in multiple embryonic cell types and plays important roles in proliferation, differentiation and survival of ...